共 21 条
[1]
METHOTREXATE IN RHEUMATOID-ARTHRITIS - TOXIC EFFECTS AS THE MAJOR FACTOR IN LIMITING LONG-TERM TREATMENT
[J].
ARTHRITIS AND RHEUMATISM,
1989, 32 (06)
:671-676
[2]
THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS
[J].
ARTHRITIS AND RHEUMATISM,
1988, 31 (03)
:315-324
[3]
Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis
[J].
ARTHRITIS AND RHEUMATISM,
2008, 58 (01)
:73-81
[4]
Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis
[J].
ARTHRITIS AND RHEUMATISM,
2006, 54 (10)
:3095-3103
[7]
Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis
[J].
ARTHRITIS AND RHEUMATISM,
1996, 39 (02)
:272-276
[8]
Hornung N, 2004, J RHEUMATOL, V31, P2374
[10]
METHOTREXATE FOR RHEUMATOID-ARTHRITIS - SUGGESTED GUIDELINES FOR MONITORING LIVER TOXICITY
[J].
ARTHRITIS AND RHEUMATISM,
1994, 37 (03)
:316-328